Schedule of Antidilutive Securities Excluded from Computation of Net Loss Per Common Share (Details) - Titan Pharmaceuticals Inc [Member] - shares shares in Thousands |
12 Months Ended | |
|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
|
| Anti-dilutive Securities Excluded from Computation of Earnings Per Share, Amount | 1,169 | |
| Convertible Preferred Stock [Member] | ||
| Anti-dilutive Securities Excluded from Computation of Earnings Per Share, Amount | 593 | |
| Convertible Notes [Member] | ||
| Anti-dilutive Securities Excluded from Computation of Earnings Per Share, Amount | 7 | |
| Employee Stock Awards [Member] | ||
| Anti-dilutive Securities Excluded from Computation of Earnings Per Share, Amount | 92 | |
| Warrant [Member] | ||
| Anti-dilutive Securities Excluded from Computation of Earnings Per Share, Amount | 477 | |